Vasa Denticity Q1 FY27 Share Price & Earnings Call Analysis
- Market cap
- ₹753 Cr
- P/E
- 62.27
- ROE
- 4.88%
- PEG
- -141.51
- Price to sales
- 2.52
- Debt to equity
- 0.00
- 52W high / low
- ₹610 / ₹337
- Sales growth (5Y)
- 46.94%
- EBITDA margin
- 4.42%
- Net profit margin
- 2.73%
- Promoter holding
- 60.19%
- Sales (last year)
- ₹299 Cr
Incorporated in 2016, Vasa Denticity Limited is in the business of marketing and distribution of a comprehensive portfolio of Dental Products.[1]
Guidance scorecard · Q1 FY27 call
What Vasa Denticity Ltd's management guided
and where it ranks in Healthcare Equipment & Supplies
Healthcare Equipment & Supplies
RevenueQ1 FY27 call
10–20%- The company aims to achieve revenue between ₹800 to ₹1200 crores over the next 5 years, indicating strong growth aspirations.
- Revenue growth targets for FY27 are around ₹500-600 crores and ₹800-1200 crores for FY28, reflecting ambitious scaling plans.
- Growth is expected to be driven primarily by increasing average order value and repeat purchases rather than acquiring new customers.
- There is a focus on increasing order frequency and customer wallet share through strategies like discounts on multiple items and tech solutions offering incentives.
- New business lines like digital dentistry equipment (intraoral scanners, 3D printers) are becoming significant growth drivers.
- Organic growth is prioritized over acquisitions currently, with inorganic opportunities considered only if organic growth plateaus.
2 more points from Vasa Denticity Ltd's call on revenue
Create a free account to keep reading this call
MarginsQ1 FY27 call
Up 0–2%See what Vasa Denticity Ltd said on margins — free account, 30 seconds.
CapexQ1 FY27 call
Planned- The company is focusing on building control through in-house brands to ensure quality, pricing, and product availability, which involves capital and attention investment in these portfolios.
- Inventory management and supply chain improvements are being made, including forward deployment and demand forecasting to reduce stockouts and improve delivery times, implying operational capital investment.
- The company is optimizing warehousing and logistics, with initiatives like Insta Dent for same-day/next-day delivery, requiring investment in regional warehouses.
2 more points from Vasa Denticity Ltd's call on capex
Create a free account to keep reading this call
FundraisingQ1 FY27 call
None plannedSee what Vasa Denticity Ltd said on fundraising — free account, 30 seconds.
Order bookQ1 FY27 call
- The focus is on increasing orders per customer and number of customers, with strategies planned though no definitive guidance on growth percentages yet.
- Order volumes showed growth: quarter volumes moved from 1.58 lakh & 1.82 lakh (previous year) to 1.75 lakh & 2.04 lakh recently after correction of internal errors.
- Average order value increased by about 27% largely due to higher ticket-size products; order volume growth was around 8%.
2 more points from Vasa Denticity Ltd's call on the order book
Create a free account to keep reading this call
Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Equipment & Supplies
on management's own guidance
- Strong growth2
- Strong growth1
- Q-Line BiotechGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Healthcare Equipment & Supplies companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Flat | ₹627 Cr | 21.4 | |
| 2 | 40%+ | Flat | ₹147 Cr | 16.8 | |
| 3 | Q-Line Biotech | 20–40% | Up 2%+ | ₹1,467 Cr | 25.9 |
| 4 | 20–40% | Flat | ₹18,144 Cr | 83.6 | |
| 5 | 20–40% | Flat | ₹173 Cr | 35.0 | |
| 6 | 10–20% | Up 2%+ | ₹170 Cr | 18.8 |
Sign up free to see every company in the sector ranking and track Vasa Denticity Ltd.
Pro shows every company guiding 40%+ revenue growth →Full Healthcare Equipment & Supplies rankingVasa Denticity Ltd announcements
All announcements →- Acquisition / mergerNotable· Adverse for the businessVasa Denticity shareholders ratify cancellation of 31.08% IDS Denmed stake purchase
- Board / shareholder meeting outcomeNotableVasa Denticity Limited holds 10th AGM via video conferencing on Sept 29, 2026
Financials of Vasa Denticity Ltd
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Vasa Denticity Ltd
Quarterly Results
Quarter-by-quarter operating performance
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 35.56 | 40.71 | 36.80 | 57.02 | 53.54 | 59.39 | 62.83 | 72.80 | 60.02 | 72.72 | 71.47 | 72.41 |
| Expenses + | 32.30 | 37.14 | 33.34 | 48.88 | 48.91 | 52.99 | 57.30 | 66.28 | 56.86 | 66.65 | 69.64 | 72.19 |
| Operating Profit | 3.26 | 3.57 | 3.46 | 8.14 | 4.63 | 6.40 | 5.53 | 6.52 | 3.16 | 6.07 | 1.83 | 0.22 |
| OPM % | 9.17% | 8.77% | 9.40% | 14.28% | 8.65% | 10.78% | 8.80% | 8.96% | 5.26% | 8.35% | 2.56% | 0.30% |
| Other Income + | 0.14 | 1.16 | 0.29 | 0.46 | 0.32 | 0.97 | 0.45 | 0.19 | 0.98 | 0.66 | 0.93 | 2.08 |
| Interest | 0.03 | 0.02 | 0.01 | 0.01 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.10 | 0.02 |
| Depreciation | 0.22 | 0.23 | 0.27 | 0.28 | 0.37 | 0.28 | 0.50 | 0.56 | 0.27 | 0.34 | 0.56 | 0.61 |
| Profit before tax | 3.15 | 4.48 | 3.47 | 8.31 | 4.58 | 7.09 | 5.48 | 6.15 | 3.87 | 6.39 | 2.10 | 1.67 |
| Tax % | 19.37% | 16.74% | 29.39% | 23.59% | 25.55% | 24.40% | 27.19% | 29.76% | 25.84% | 21.91% | 25.71% | 19.16% |
| Net Profit + | 2.55 | 3.73 | 2.45 | 6.35 | 3.42 | 5.37 | 3.99 | 4.32 | 2.87 | 4.99 | 1.56 | 1.36 |
| EPS in Rs | 1.59 | 2.33 | 1.53 | 3.96 | 2.14 | 3.35 | 2.40 | 2.60 | 1.73 | 2.88 | 0.90 | 0.78 |
Financials of Vasa Denticity Ltd
Profit & Loss
Annual income statement trend
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales + | 30 | 40 | 77 | 123 | 170 | 241 | 277 |
| Expenses + | 30 | 40 | 71 | 113 | 151 | 218 | 265 |
| Operating Profit | 0 | 0 | 6 | 10 | 19 | 23 | 11 |
| OPM % | 1% | 1% | 7% | 8% | 11% | 10% | 4% |
| Other Income + | 0 | 0 | 0 | 0 | 1 | 2 | 5 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 2 | 2 |
| Profit before tax | 0 | 0 | 5 | 10 | 19 | 23 | 14 |
| Tax % | -0% | 27% | 0% | 24% | 22% | 27% | 23% |
| Net Profit + | 0 | 0 | 5 | 8 | 15 | 17 | 11 |
| EPS in Rs | 4.50 | 16.50 | 250.00 | 5.92 | 9.42 | 10.28 | 6.22 |
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | -0% |
Financials of Vasa Denticity Ltd
Balance Sheet
Capital structure and asset base
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.20 | 0.20 | 0.20 | 13 | 16 | 17 | 17 |
| Reserves | 0 | 0 | 6 | 3 | 52 | 116 | 157 |
| Borrowings + | 1 | 2 | 3 | 1 | 0 | -0 | -0 |
| Other Liabilities + | 4 | 4 | 10 | 11 | 17 | 17 | 21 |
| Total Liabilities | 5 | 7 | 19 | 28 | 86 | 150 | 196 |
| Fixed Assets + | 0 | 0 | 1 | 2 | 2 | 15 | 23 |
| CWIP | -0 | -0 | -0 | -0 | 1 | 5 | -0 |
| Investments | -0 | -0 | -0 | -0 | 12 | 44 | 45 |
| Other Assets + | 4 | 6 | 18 | 26 | 70 | 86 | 128 |
| Total Assets | 5 | 7 | 19 | 28 | 86 | 150 | 196 |
Financials of Vasa Denticity Ltd
Cash Flows
Operating, investing and financing cash movement
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 1 | -0 | 0 | 2 | -11 | -5 | -27 |
| Cash from Investing Activity + | -0 | -1 | -0 | -1 | -22 | -42 | -4 |
| Cash from Financing Activity + | -0 | 1 | 1 | -0 | 36 | 47 | 30 |
| Net Cash Flow | 0 | -0 | 1 | 1 | 3 | 0 | -1 |
| Free Cash Flow | 0 | -1 | -0 | -0 | -14 | -23 | -31 |
| CFO/OP | 348% | -84% | 9% | 40% | -35% | 6% | -203% |
Financials of Vasa Denticity Ltd
Ratios
Working capital efficiency and return ratios
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 10 | 7 | 6 | 3 | 24 | 21 | 15 |
| Inventory Days | 34 | 30 | 63 | 70 | 99 | 112 | 150 |
| Days Payable | 44 | 30 | 32 | 28 | 33 | 23 | 26 |
| Cash Conversion Cycle | 0 | 6 | 37 | 45 | 90 | 110 | 139 |
| Working Capital Days | -5 | -8 | 19 | 36 | 84 | 95 | 189 |
| ROCE % | 29% | 95% | 80% | 45% | 22% | 9% |
Guidance history
How Vasa Denticity Ltd's guidance has moved, call by call
| Call | Revenue | Margins | Capex | Fundraising | Order book |
|---|---|---|---|---|---|
| Q1 FY27 call → | 10–20% | Up 0–2% | Planned | None planned | — |
| Q4 FY26 call → | 20–40% | Up 2%+ | Planned | None planned | — |
| Q2 FY26 call → | 10–20% | Up 0–2% | None planned | — | Flat |
What management guided on each call, newest first. Not investment advice, and not a forecast of returns.
Momentum score · price trend
24 out of 100 — Cooling
Over the past year its share price has done worse than most of the stocks we track.
| Period | Share price change | Better than … of 1,910 stocks |
|---|---|---|
| Last 12 months | −27.4% | 28% |
| Last 6 months | −4.2% | 49% |
| Last 3 months | +10.4% | 82% |
The price is 44.9% below its all-time high of ₹789.6 (13 Dec 2024). Stocks more than 20% below their peak have their score halved, so 47 became 24.
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Vasa Denticity Ltd: 0.4 × 28 + 0.4 × 49 + 0.2 × 82 = 47, halved to 24 because the price is more than 20% below its all-time high.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 30 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Continue your research
What Vasa Denticity Ltd's management said in earlier quarters
Others in Healthcare Equipment & Supplies this season
- Galaxy Medicare (Q2 FY27)
Revenue from Operations (₹ Mn): . Key investor presentation takeaways from Galaxy Medicare's Q2 FY27 investor presentation — and how it ranks against sector pee
- Nureca Ltd (Q2 FY27)
Year-on-year growth in revenue from operations: approximately 55% increase (585.99 vs 378.41 million standalone) . Key results statement takeaways from Nureca's
- Aprameya Engineering Ltd (Q2 FY26)
H1FY26 Revenue from Operations: Rs 421.4 Mn, up 343% YoY from Rs 92.7 Mn in H1FY25. Key investor presentation takeaways from Aprameya Engineering Ltd's Q2 FY26
- Nureca Ltd (Q2 FY26)
Q2 FY26 Revenue from Operations: INR 528 million, a 7% year-on-year (YoY) growth from INR 493 million in Q2 FY25. Key investor presentation takeaways from Nurec